A prior report demonstrated that IL-33 alleviates hepatic steatosis in high-fat diet-induced murine MAFLD (10), while another demonstrated a harmful role in the face of diabetes and MASH (11). The gene discussed is IL33; the disease is Hepatic steatosis.